New Stock News: Dabe Biotechnology to file for listing on the Hong Kong Stock Exchange, focusing on deep cultivation in the field of weight management.

According to the financial news app Yitong Finance, it was revealed by the Hong Kong Stock Exchange on September 19 that Hangzhou Xianweida Biotechnology Co., Ltd.-B (referred to as Xianweida Biotechnology) has submitted an application for listing on the main board of the Hong Kong Stock Exchange. Morgan Stanley and China International Capital Corporation (CICC) are the joint sponsors.